IOVANCE BIOTHERAPEUTICS, INC. Current Liabilities
IOVANCE BIOTHERAPEUTICS, INC. (IOVA) had Current Liabilities of $106.85 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2026-08-06
- 2026-06-30: Liabilities, Current $106.85M.
- 2026-03-31: Liabilities, Current $129.42M.
- 2025-12-31: Liabilities, Current $138.36M.
- 2025-09-30: Liabilities, Current $125.78M.
| Period end | Liabilities, Current | Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $106.85M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $129.42M 10-Q · filed 2026-05-07 | |
| 2025-12-31 | $138.36M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $125.78M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $129.16M 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $122.69M 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $122.34M 10-K · filed 2026-02-24 | |
| 2024-09-30 | $118.06M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $93.64M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $83.21M 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $110.31M 10-K · filed 2025-02-27 | |
| 2023-09-30 | $90.95M 10-Q · filed 2023-11-07 | |
| 2023-06-30 | $88.64M 10-Q · filed 2023-08-08 | |
| 2023-03-31 | $87.27M 10-Q · filed 2023-05-10 | |
| 2022-12-31 | $91.48M 10-K · filed 2024-02-28 | |
| 2022-09-30 | $79.25M 10-Q · filed 2022-11-03 | |
| 2022-06-30 | $64.19M 10-Q · filed 2022-08-04 | |
| 2022-03-31 | $77.08M 10-Q · filed 2022-05-05 | |
| 2021-12-31 | $89.20M 10-K · filed 2023-02-28 | |
| 2021-09-30 | $64.77M 10-Q · filed 2021-11-04 | |
| 2021-06-30 | $60.53M 10-Q · filed 2021-08-05 | |
| 2021-03-31 | $55.06M 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $54.87M 10-K · filed 2022-02-24 | |
| 2020-09-30 | $64.39M 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $54.91M 10-Q · filed 2020-08-06 | |
| 2020-03-31 | $39.55M 10-Q · filed 2020-05-05 | |
| 2019-12-31 | $39.08M 10-K · filed 2021-02-25 | |
| 2019-09-30 | $34.61M 10-Q · filed 2019-11-04 | |
| 2019-06-30 | $33.84M 10-Q · filed 2019-08-01 | |
| 2019-03-31 | $22.14M 10-Q · filed 2019-05-07 | |
| 2018-12-31 | $14.40M 10-K · filed 2020-02-25 | |
| 2018-09-30 | $16.67M 10-Q · filed 2018-11-06 | |
| 2018-06-30 | $14.18M 10-Q · filed 2018-08-07 | |
| 2018-03-31 | $14.69M 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $9.60M 10-K · filed 2019-02-28 | $9.89M 10-K · filed 2018-03-12 |
| 2017-09-30 | $8.53M 10-Q · filed 2017-11-02 | |
| 2017-06-30 | $8.86M 10-Q · filed 2017-08-03 | |
| 2017-03-31 | $5.50M 10-Q · filed 2017-05-03 | |
| 2016-12-31 | $4.97M 10-K · filed 2018-03-12 | |
| 2016-09-30 | $3.19M 10-Q · filed 2016-11-04 | |
| 2016-06-30 | $4.61M 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $1.83M 10-Q · filed 2016-05-09 | |
| 2015-12-31 | $1.63M 10-K · filed 2017-03-09 | |
| 2015-09-30 | $2.85M 10-Q · filed 2015-11-06 | |
| 2015-06-30 | $1.87M 10-Q · filed 2015-08-10 | |
| 2015-03-31 | $1.91M 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $1.66M 10-K · filed 2016-03-11 | $1.66M 10-K · filed 2015-03-16 |
| 2014-09-30 | $1.26M 10-Q · filed 2014-11-13 | |
| 2014-06-30 | $1.16M 10-Q · filed 2014-08-08 | |
| 2014-03-31 | $1.11M 10-Q · filed 2014-05-14 | |
| 2013-12-31 | $2.27M 10-K · filed 2015-03-16 | |
| 2013-09-30 | $3.51M 10-Q · filed 2013-11-14 | |
| 2013-06-30 | $3.37M 10-Q · filed 2013-10-23 | |
| 2013-03-31 | $12.31M 10-Q · filed 2013-10-23 | |
| 2012-12-31 | $11.35M 10-K · filed 2014-03-28 | |
| 2012-09-30 | $16.61M 10-Q · filed 2013-01-25 | |
| 2012-06-30 | $16.68M 10-Q/A · filed 2012-09-10 | |
| 2012-03-31 | $17.34M 10-Q · filed 2012-05-15 | |
| 2011-12-31 | $13.35M 10-K · filed 2013-09-23 | |
| 2011-09-30 | $9.13M 10-Q · filed 2011-11-21 | |
| 2011-06-30 | $1.87M 10-Q/A · filed 2011-09-01 | |
| 2010-12-31 | $822.87K 10-K · filed 2012-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adaptive Biotechnologies Corp (ADPT) | United States | $4.719B | -53.43 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 | |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Greenland Mines Ltd (GRML) | United States | $2.362B |